Trimethylamine N-oxide (TMAO) is a metabolite produced from dietary choline and carnitine by gut bacteria, further processed in the liver. Elevated blood levels are linked to an increased risk of cardiovascular disease, including atherosclerosis and thrombosis.
Trimethylamin-N-Oxid is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Trimethylamin-N-Oxid is most useful when it is interpreted together with the symptom pattern, the relevant category context, and the broader diagnostic question behind the test.
Trimethylamin-N-Oxid does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Trimethylamine N-oxide (TMAO) is a small organic compound that originates from the breakdown of certain nutrients—especially choline and carnitine found in red meat, eggs, and fish—by gut bacteria. These bacteria convert choline and carnitine into trimethylamine (TMA), which is then absorbed into the bloodstream and oxidized by the liver to TMAO.
TMAO has gained attention as a novel risk marker for cardiovascular disease, as high concentrations are associated with enhanced cholesterol deposition in artery walls, increased platelet reactivity, and a greater tendency for blood clots. Measuring TMAO levels in blood or urine is primarily used in research and specialized clinical settings to assess cardiovascular risk beyond traditional markers.
TMAO values are typically interpreted relative to an upper cut-off rather than a lower limit. Concentrations below 6.2 µmol/L are generally considered low risk, as this falls within the typical reference range. Since TMAO is a risk marker, lower levels are associated with a lower cardiovascular risk profile and may reflect a diet lower in animal products or a beneficial gut microbiota composition.
A TMAO level above 6.2 µmol/L (lab-dependent) may suggest an increased risk for cardiovascular events, as elevated TMAO is linked to atherosclerosis and thrombosis. High levels can result from a diet rich in red meat and eggs, certain gut microbiota configurations, or reduced kidney function, since TMAO is cleared renally.
In research, concentrations >6.2 µmol/L have been associated with a higher rate of major adverse cardiovascular events, but TMAO is not yet a routine clinical test and should be interpreted alongside other risk factors.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Trimethylamin-N-Oxid is most useful when it is interpreted together with the symptom pattern, the relevant category context, and the broader diagnostic question behind the test.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Trimethylamine N-oxide (TMAO) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
TMAO reflects the interplay between diet, gut bacteria, and liver metabolism. It measures a metabolite that may promote plaque buildup in arteries and increase clotting risk, serving as a marker for potential cardiovascular disease.
There is no universally established normal range, but many studies consider a TMAO concentration below 6.2 µmol/L as lower risk. Reference intervals are lab-dependent, and results should be discussed with a healthcare provider.
Some research suggests that reducing red meat and egg intake, or increasing plant-based foods, may lower TMAO levels. However, TMAO management is not yet a standardized medical recommendation; always consult your doctor before making significant dietary changes.
Trimethylamin-N-Oxid does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
Trimethylamin-N-Oxid is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
